Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis
European Journal of Immunology · 2026-10 · 56 (10)
DOI: 10.1002/eji.70297 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 14.10.2026. Verfasst von Aleksandra Lopez Krol und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Colitis, Cyclic AMP Response Element Modulator, Glycolysis. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Wilhelm-Sander Foundation, Gutenberg Research College Fellowship of the Johannes Gutenberg University Mainz.
Abstract (Originalsprache)
Regulatory T cells (Tregs) are essential for immune tolerance, with cAMP metabolism central to their suppressive function. Inducible cAMP early repressor (ICER) is a negative regulator of cAMP signalling. However, its role in Treg biology is not fully understood. Here we generated Foxp3‐specific ICER knockout mice to assess ICER's function in Tregs. We found that ICER deficiency does not impair Treg development or suppression of effector T cell proliferation under homeostatic conditions. However, ICER‐deficient Tregs display enhanced Foxp3 stability, increased glycolysis and proliferation but exhibit impaired suppression of IFN‐γ production by effector T cells. In a dextran sodium sulphate‐induced colitis model, loss of ICER in Tregs led to aggravated intestinal inflammation and tissue damage, without, however, a marked effect on gross disease parameters. These results identify ICER as a context‐dependent modulator of Treg metabolism and inflammatory cytokine control, highlighting its potential role in regulating immune responses during inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
- Institute of Pathology, University Medical Center Mainz, Mainz, Germany.
- Translational Oncology at the University Medical Center Mainz (TRON), Mainz, Germany.
- Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.
- Institute of Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Förderung
- German Research Foundation
- Wilhelm-Sander Foundation
- Gutenberg Research College Fellowship of the Johannes Gutenberg University Mainz
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Lopez Krol, A., Silva, L., Nascimento, D. C., Oberwalder, S. M., Chawla, H., de Carvalho, G. A. B., Boukhallouk, F., Romero, M., Hausen, A., Gaida, M. M., Berod, L., Alves-Filho, J. C., & Sparwasser, T. (2026). Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis. European Journal of Immunology, 56(10). https://doi.org/10.1002/eji.70297
Vancouver
Lopez Krol A, Silva L, Nascimento DC, Oberwalder SM, Chawla H, de Carvalho GAB, et al. Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis. European Journal of Immunology. 2026;56(10). doi:10.1002/eji.70297
BibTeX
@article{LopezKrol2026,
author = {Lopez Krol, Aleksandra and Silva, Luana and Nascimento, Daniele C and Oberwalder, Sophie M and Chawla, Hitikk and de Carvalho, Gabriel Alberto Barbosa and Boukhallouk, Fatima and Romero, Monica and Hausen, Anne and Gaida, Matthias M and Berod, Luciana and Alves-Filho, José Carlos and Sparwasser, Tim},
title = {Inducible cAMP Early Repressor Limits Glycolytic Programming in Regulatory T Cells and Supports Control of Inflammatory Colitis},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {10},
doi = {10.1002/eji.70297}
}
EUVIMED